Search

You searched for "resistant"

495 results found

Who was Zoon?

1 January 2016 | URO - Infection, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). Eponyms are frowned upon in modern medical teaching but, as a medical historian,...

New techniques in UTI diagnosis

12 September 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...
The Journal of Urology cover image.

Is antibiotic prophylaxis warranted in hypospadias repairs?

4 November 2025 | | URO - Paediatrics
Hypospadias repair is a common paediatric urological procedure. Complication rates following hypospadias repair are variable (ranging from 5–10% for distal hypospadias repairs and as high as 32–70% for proximal repairs). Limiting surgical site infections by minimising infection through antibiotic prophylaxis...

European Urology Residents Education Programme (EUREP)

1 May 2015 | | URO - Core Urology
The EAU’s 12th European Urology Residents Education Programme (EUREP) was held from 5-10 September 2014. We were fortunate to attend as part of a small contingent of UK urology registrars who had applied and been selected to attend. The programme...
Urology journal cover image.

PDE5I in LUTS – how do they work – no proof yet

1 September 2014 | | URO - Basic Science Research, URO - Endourology & Stones, URO - Functional / Reconstructive Urology
Phosphodiesterase type 5 (PDE5) inhibitors used in erectile dysfunction (ED) have been shown to improve lower urinary tract symptoms (LUTS) as well. The mechanism is not well understood. One of the hypotheses for benign prostatic hyperplasia (BPH) – LUTS is...

Andrology (2016)

1 July 2016 | | URO - Andrology
Case 1 Image A. Image B. Who is the mythological figure depicted in image A and how does he relate to a urological emergency? Define priapism and list five causes. In the context of a patient presenting with priapism, what...

The pioneer women in British urology

5 January 2022 | | URO - Core Urology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined by Kassie Ball, a urology trainee, who approached...

In conversation with Nadine Coull

5 October 2022 | URO - Core Urology
We were delighted to chat to Nadine Coull, the new President of the Royal Society of Medicine Section of Urology about her career so far and aims for the year ahead. Can you tell us a little bit about what...

Urology in Leeds

2 July 2025 | | URO - Technology
In this series of articles, I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). One of the reasons for the creation of the Museum of Urology was...

Men with a susceptibility to prostate cancer: implications of ethnicity in PCa risk-prediction and diagnosis

5 January 2022 | | URO - Urologic Oncology
The diagnostic and therapeutic landscapes of prostate cancer (PCa) have advanced at great pace in the past decade. However, disparities in access to care, clinical outcomes and representation in therapeutic, interventional and genomic studies continue to exist between Afro-Caribbean (AC)...

Stereotactic body radiotherapy for oligometastatic disease secondary to urological cancer

1 January 2016 | | URO - Urologic Oncology, URO - Technology
The concept of oligometastatic disease is controversial. The traditional model of cancer, which most of us learnt at medical school, is of a disease which starts confined to an organ, for example the prostate, where it can be cured with...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...